COVID-19 rapid NICE guideline on severe asthma

NICE has published new rapid guidelines on the active management of patients with suspected and confirmed COVID-19, and in patients without COVID-19. The guidelines have been designed to maximise the safety of patients whilst enabling services to make the best use of NHS resources.

The guideline on severe asthma says that people should continue to take their treatment as prescribed and only attend essential appointments alone, if possible, to minimize the risk of infection.

The guideline recommends that patients should be advised to regularly clean equipment such as face masks and mouthpieces and that they should not share their inhalers and devices with anyone else.

Loading...

Taking too long?

Reload document

| Open in new tab

Download [84.79 KB]

Click here to access the COVID-19 rapid guideline on severe asthma

Click here to access the COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community

Click here to access the COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders

Click here to access the COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community

© NICE 2020 COVID-19 rapid guideline on severe asthma. Available from the NICE website by clicking here. All rights reserved. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication. This guidance is published under the NICE-UK open content licence. You can access this licence by clicking here. The information above was correct at the time of publishing. This information is approved for use in the UK only.

Click here to read the Pharmacy in Practice Disclaimer. Click here to read your responsibility in regard to using NICE guidelines.